Document is current
Any future updates will be listed below
-
Authors
Fernández-Barat, Laia http://orcid.org/0000-0001-7528-9636
Motos, Ana
Panigada, Mauro
Álvarez-Lerma, Francisco
Viña, Lucía
Lopez-Aladid, Ruben
Ceccato, Adrian
Bassi, Gianluigi Li
Nicolau, David P.
Lopez, Yuli
Muñoz, Laura
Guerrero, Laura
Soy, Dolors
Israel, Trinidad
Castro, Pedro
Torres, Antoni
-
Funding
Funding for this research was provided by:
CIBER de enfermedades respiratorias- Ciberes (CB 06/06/0028)
Pfizer (WI173058)
Pfizer (ASPIRE award 2011)
Institució Catalana de Recerca i Estudis Avançats (ICREA Academy)
IDIBAPS (2.603)
Generalitat de Catalunya (SGR)
- License Information
-
More Information
Article History
Received: 15 April 2019
Accepted: 21 June 2019
First Online: 10 July 2019
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: A. Torres has received grants from MedImmune, Cubist, Bayer, Theravance, and Polyphor and personal fees as Advisory Board member from Bayer, Roche, The Medicines CO, and Curetis. He has received personal speaker’s bureau fees from GSK, Pfizer, Astra Zeneca, and Biotest Advisory Board, unconnected to the study submitted here.
